10507477Woodle ES, Xu D, Zivin RA, Auger J, Charette J, O'Laughlin R, Peace D, Jollife LK, Haverty T, Bluestone JA, Thistlethwaite JRTransplantationGraft Rejection; Immunosuppressive Agents; Kidney Transplantation; Muromonab-CD3; Receptors, FcAcute Disease; Adult; Antigens, CD; Cytokines; Dose-Response Relationship, Drug; Female; Half-Life; Humans; Male; Middle Aged; Treatment OutcomePhase I trial of a humanized, Fc receptor nonbinding OKT3 antibody, huOKT3gamma1(Ala-Ala) in the treatment of acute renal allograft rejection. Transplantation. 1999 Sep 15; 68(5):608-16.Transplantation1999-09-15T00:00:001999Phase I trial of a humanized, Fc receptor nonbinding OKT3 antibody, huOKT3gamma1(Ala-Ala) in the treatment of acute renal allograft rejection.prns:fullNamefull nameprns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:hasSubjectAreaMajorTopicListhas major subject area listprns:hasSubjectAreaMinorTopicListhas minor subject area listprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed Identifiervivo:authorRankauthor rank in publicationAuthorshipDepartmentvivo:hasSubjectAreahas subject areavivo:hrJobTitleHR job titleInformation Resourcevivo:informationResourceInAuthorshipauthorsvivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonD000208Disorders3298240.843097Acute DiseaseD000328Living Beings1578255770.254432AdultD007166Chemicals & Drugs2179770.66626Immunosuppressive AgentsD006084Physiology14710640.636466Graft RejectionD006207Concepts & Ideas61960.98167Half-LifeD004305Concepts & Ideas52019580.724084Dose-Response Relationship, DrugD008875Concepts & IdeasLiving Beings1473249570.258811Middle AgedD005260Physiology1992444050.191167FemaleD011961Chemicals & Drugs25330.971899Receptors, FcD006801Living Beings2262862810.130052HumansAuthorship 1650411D008297Physiology1931408600.201617Male0.1825810.1825811authors10.2516has subject areaD016030Procedures1408460.60258Kidney TransplantationD016853Chemicals & Drugs17690.982272Muromonab-CD3D015703Chemicals & Drugs1834570.850205Antigens, CDD016896Concepts & Ideas101179490.402389Treatment OutcomeD016207Chemicals & Drugs3167750.733983CytokinesUniversity of ChicagoJ.ThistlethwaiteJ. Richard Thistlethwaite41.78927490000000-87.60125000000000546Thistlethwaite, J.Emeritus/Emerita, Professortrue1Emeritus/Emerita, ProfessorEmeritus/Emerita, ProfessorSurgery-Transplant